World Health Organization

Update of the WHO guidance on the treatment of drug susceptible TB

The World Health Organization (WHO) is convening a Guideline Development Group (GDG) to advise on updates needed to its recommendations on the treatment of drug susceptible tuberculosis (TB).

Read More →

TB outbreaks in schools: experiences from the Western Pacific Region

The World Health Organization Regional Office for the Western Pacific released a report summarizing current evidence on TB outbreaks in schools and contextualizing the information within the Western Pacific Region. Case studies from four countries highlighted the diverse range of experiences in the Region. As many countries have minimal experience in preventing and responding to TB outbreaks in schools, evidence from past outbreaks and case studies from a few countries could inform future responses.

Read More →

WHO announces updated definitions of TB treatment outcomes

8 April 2021, Geneva | The definitions of tuberculosis (TB) treatment outcomes have been revised by the World Health Organization (WHO)’s Global Tuberculosis Programme. New definitions of treatment outcomes will standardise the assessment of treatment outcomes for all TB patients and all treatment regimens regardless of drug-resistance status, type of drugs used or duration of treatment.

Read More →

Call for expressions of interest: Systematic reviews on hepatitis B and hepatitis C co-infection with TB and MDR/RR-TB and the effects of co-administration of MDR/RR-TB and hepatitis C treatment

The World Health Organization (WHO) Global TB Program has initiated a process to conduct systematic reviews for the collection and assessment of available evidence on the prevalence of viral hepatitis B and C among patients with TB and multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB) and whether the concurrent treatment of drug-resistant TB and hepatitis C is safe and increases the likelihood of treatment success and reduces unfavourable treatment outcomes.

Read More →

Call for experts: Technical Advisory Group on TB Diagnostics and Laboratory Strengthening

The World Health Organization (WHO) Global TB Program is announcing a call for experts to serve as members of the Technical Advisory Group on TB Diagnostics and Laboratory Strengthening to advise WHO on technical aspects related to the assessment and implementation of TB diagnostic tools and TB diagnostic strategies.

Read More →

Call for expressions of interest: Expert(s) for conducting data synthesis and analysis on the use of new regimens for the treatment of DR-TB

The World Health Organization (WHO) Global TB Program has initiated a process to update the consolidated guidelines on the treatment of drug-resistant TB (DR-TB). The WHO Global TB Program is seeking support from independent researchers, academic institutions or other entities with relevant expertise and experience in systematic review and statistical analysis to perform the synthesis and analysis of the available data on new DR-TB treatment regimens for the guideline update.

Read More →

WHO: World TB Day newsletter

The World Health Organization (WHO) released a special edition of its newsletter in commemoration of World TB Day, 24 March, highlighting #EndTB messages and statements from global leaders, video recordings of conducted events, released materials and documents, and other related news and updates from the organization.

Read More →

COVID-19 highlights urgent need to reboot global effort to end TB

An estimated 1.4 million fewer people received care for TB in 2020 than in 2019 - a reduction of 21% from 2019, according to preliminary data compiled by the World Health Organization.

Read More →

Call for expressions of interest: Data Curator for the Global individual patient data platform for drug-resistant TB treatment

16 March 2021, Geneva | The World Health Organization Global Tuberculosis Programme has initiated a process for the establishment of Global individual patient data platform for drug-resistant tuberculosis treatment (DR-TB IPD). The DR-TB IPD is a shared platform and collaborative initiative to generate reliable evidence on drug-resistant TB treatment to inform future TB treatment guidelines and be available for researchers to analyse. The purpose of the DR-TB IPD is to facilitate pooling of individual patient data issued from researchers, local or national databases in the context of drug-resistant TB treatment and facilitate policy update, development and public health research. It will be supported by the WHO Global TB Programme and maintained by the selected Data Curator. Data Curator is the entity in charge of maintenance, curation and hosting of the DR-TB IPD.

Read More →

WHO World TB Day online talk show

The World Health Organization (WHO) is organizing a special virtual talk show to commemorate World TB Day on 24 March at 13:00H CET. This will put the spotlight on TB in the midst of the ongoing COVID crisis.

Read More →

Page 1 of 28 · Total posts: 10

1 2 Last→